3Korth C, Keneko K, Prusiner SB. Expression of unglycosylated mutated prion protein facilitates prp(sc) formation in neuroblastoma cells infected with different prion strains. J Gen Virol, 2000, 10:2655-2663.
4Harrison PM, Chan HS, Prusiner SB, et al. Confomational propagation with prion-like characteristics in a simple model of protein folding. Protein Sci, 2001,10: 819-835.
5Requena JR, Groth D, Legname G, et al. Copper-catalyzed oxidation of the recombinant Sha(29-231) prion protein. Proc Natl Acad Sci USA, 2001,98: 7170-7175.
6Parchi P, Zon W,Wang W, et al . Genetic influence on the structural variation of the abnormal prion protein, Proc Natl Acad Sci USA,2000,97: 10168-10172.
7WHO Veterinary Public Health Unit. Report of a WHO consultation on public health issues related to human & animal transmissible spongiform encephalopathies. Geneva, 1995.7.
8Tuite MF. Cell biology. Sowing the protein seeds of prion propagation. Science, 2000,289: 556-557.
9Perrier V, Wallace AC, Kaneko K. Minicking dominant negative inhibition of prion replication through structrue-based drug design.Proc Natl Acad Sci USA,2000,97: 6073-6078.
10Korth C, May BC, Cohen FE, et al. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA,2001,98: 1830-1841.
